Many studies have found that telomeres of leukemic cells in CML patients are highly variable but generally shorter than those of age-matched healthy individuals or BCR/ABL-negative T lymphocytes from the same patients, along with a slightly increased telomerase activity [233,234,266]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.